Work

Abstract 5699: AMV564, a bivalent, bispecific T-cell engager, depletes myeloid-derived suppressor cells and activates T cells in cancer patients

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2020-5699

Authors: Victoria Smith, Sterling Eckard, Michael P. Rettig, Leah N. Gehrs, Jeanmarie Guenot, Sheng Wei, John F. DiPersio

Institutions: Washington University in St. Louis, Moffitt Cancer Center

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3083221023

Cites:

Cited by: 6

Related to: 10